ARTIZAN BIOSCIENCES
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 17 Nov 2026, and its filing window is open now).
Record
- Serial number
- 87176646
- Registration number
- 6200643
- Mark type
- Word mark
- Filed
- 20 Sept 2016
- Published for opposition
- 07 Mar 2017
- Registered
- 17 Nov 2020
- Next maintenance filing
- §8 declaration of use, due by 17 Nov 2026 (grace period to 17 May 2027)
- Attorney of record
- Catherine Intravia
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services, namely, development of small molecule drugs for use in humans
Owner
- Artizan Biosciences, Inc., Durham, NC, US
- Artizan Biosciences, Inc., Durham, NC, US
- Artizan Biosciences, Inc., Durham, NC, US
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 04 May 2020 — USE AMENDMENT FILED
- 11 Sept 2020 — NOTICE OF REINSTATEMENT E-MAILED
- 09 Sept 2020 — REINSTATED
- 09 Sept 2020 — PETITION TO DIRECTOR GRANTED
- 13 Jul 2020 — ASSIGNED TO PETITION STAFF
- 11 Jun 2020 — TEAS STATEMENT OF USE RECEIVED
- 11 Jun 2020 — TEAS PETITION TO DIRECTOR RECEIVED
- 08 Jun 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jun 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED